SCHEMBL3768664

SCHEMBL3768664

Cc1ccccc1Oc1cccc(S(=O)(=O)Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.44
HPGD P15428 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
HSD17B10 Q99714 1/20 0.41
FFAR1 O14842 1/20 0.41
GAA P10253 1/20 0.41
GCK P35557 1/20 0.40
PGR P06401 1/20 0.40
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
ADAM17 P78536 1/20 0.39
NPC1 O15118 1/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
FFAR4 Q5NUL3 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8741352 0.87 HTT (0.46) ARHPGDMEN1KMT2AALDH1A1
SCHEMBL14018369 0.86 NR1H2 (0.49) ARHPGDMEN1KMT2AALDH1A1
SCHEMBL6497320 0.84 ALDH1A1 (0.50) ALDH1A1TDP1HSD17B10PGRTSHR
SCHEMBL6850078 0.84 CA1 (0.48) HPGDMEN1KMT2AALDH1A1GAA
SCHEMBL6299006 0.83 POLB (0.49) ARALDH1A1TDP1HSD17B10POLB
SCHEMBL1020708 0.82 SMN1; SMN2 (0.49) ARHPGDMEN1KMT2AALDH1A1
SCHEMBL27749722 0.80 PTGS2 (0.46) ARHPGDMEN1KMT2AALDH1A1
SCHEMBL2837656 0.80 ALDH1A1 (0.56) ALDH1A1TDP1HSD17B10PGRTSHR
SCHEMBL31518388 0.79 SMN1; SMN2 (0.46) MEN1KMT2AALDH1A1TDP1HSD17B10
SCHEMBL14572646 0.78 HTT (0.62) ALDH1A1TDP1FFAR1PGRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435978-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2013-05-07 US disclosed
US-20100324009-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-23 US disclosed
US-20100317644-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-16 US disclosed
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GRUENENTHAL GMBH (DE) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317644-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 AR 2421/4885HPGD 1360/4885MEN1 4354/4885
US-20100324009-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 AR 2421/4885HPGD 1360/4885MEN1 4354/4885
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS SULT2A1, STS, SULT1A1 AR 2421/4885HPGD 1360/4885MEN1 4354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.